

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 6.79683819 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 6.79683819 |
| 3 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 5.51498788 |
| 4 | ER overload response (GO:0006983) | 4.78405598 |
| 5 | signal peptide processing (GO:0006465) | 4.72085165 |
| 6 | protein retention in ER lumen (GO:0006621) | 4.61827272 |
| 7 | protein maturation by protein folding (GO:0022417) | 4.58632939 |
| 8 | exocrine pancreas development (GO:0031017) | 4.41999445 |
| 9 | COPII vesicle coating (GO:0048208) | 4.38469815 |
| 10 | endocrine pancreas development (GO:0031018) | 4.25510087 |
| 11 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.13882196 |
| 12 | peptide hormone processing (GO:0016486) | 4.11970055 |
| 13 | nuclear pore organization (GO:0006999) | 3.99254381 |
| 14 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.89427202 |
| 15 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.89135761 |
| 16 | nuclear pore complex assembly (GO:0051292) | 3.83393564 |
| 17 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 3.74589222 |
| 18 | protein targeting to Golgi (GO:0000042) | 3.71028640 |
| 19 | vesicle coating (GO:0006901) | 3.69575761 |
| 20 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 3.49558201 |
| 21 | positive regulation of nuclease activity (GO:0032075) | 3.47751762 |
| 22 | sequestering of metal ion (GO:0051238) | 3.45045675 |
| 23 | type B pancreatic cell development (GO:0003323) | 3.44232786 |
| 24 | toxin metabolic process (GO:0009404) | 3.40079621 |
| 25 | protein localization to Golgi apparatus (GO:0034067) | 3.38059687 |
| 26 | intra-Golgi vesicle-mediated transport (GO:0006891) | 3.35957558 |
| 27 | endoplasmic reticulum unfolded protein response (GO:0030968) | 3.24911905 |
| 28 | establishment of protein localization to Golgi (GO:0072600) | 3.23349844 |
| 29 | ER-associated ubiquitin-dependent protein catabolic process (GO:0030433) | 3.22919944 |
| 30 | nucleobase catabolic process (GO:0046113) | 3.22062894 |
| 31 | metaphase plate congression (GO:0051310) | 3.20423509 |
| 32 | cellular response to unfolded protein (GO:0034620) | 3.15593194 |
| 33 | mitotic sister chromatid cohesion (GO:0007064) | 3.15224342 |
| 34 | positive regulation of mitochondrial fission (GO:0090141) | 3.14402895 |
| 35 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 3.12687051 |
| 36 | ER-nucleus signaling pathway (GO:0006984) | 3.12481121 |
| 37 | insulin secretion (GO:0030073) | 3.10148286 |
| 38 | regulation of nuclease activity (GO:0032069) | 3.05860888 |
| 39 | cellular response to topologically incorrect protein (GO:0035967) | 3.03230736 |
| 40 | detection of calcium ion (GO:0005513) | 3.01931224 |
| 41 | protein N-linked glycosylation via asparagine (GO:0018279) | 3.01702535 |
| 42 | peptidyl-asparagine modification (GO:0018196) | 2.97074751 |
| 43 | inner ear receptor cell development (GO:0060119) | 2.95118449 |
| 44 | postsynaptic membrane organization (GO:0001941) | 2.92143581 |
| 45 | cullin deneddylation (GO:0010388) | 2.90651533 |
| 46 | establishment of integrated proviral latency (GO:0075713) | 2.90353490 |
| 47 | axonal fasciculation (GO:0007413) | 2.88835788 |
| 48 | pore complex assembly (GO:0046931) | 2.84649401 |
| 49 | response to endoplasmic reticulum stress (GO:0034976) | 2.83616898 |
| 50 | positive regulation of insulin secretion (GO:0032024) | 2.83326015 |
| 51 | negative regulation of DNA recombination (GO:0045910) | 2.82465420 |
| 52 | mitotic metaphase plate congression (GO:0007080) | 2.82149440 |
| 53 | glandular epithelial cell development (GO:0002068) | 2.81126594 |
| 54 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 2.80869241 |
| 55 | protein N-linked glycosylation (GO:0006487) | 2.79928940 |
| 56 | sister chromatid segregation (GO:0000819) | 2.78971330 |
| 57 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.76472596 |
| 58 | L-phenylalanine catabolic process (GO:0006559) | 2.76472596 |
| 59 | regulation of insulin secretion (GO:0050796) | 2.75072324 |
| 60 | negative regulation of glycogen biosynthetic process (GO:0045719) | 2.74071705 |
| 61 | ER to Golgi vesicle-mediated transport (GO:0006888) | 2.73337803 |
| 62 | cellular response to vitamin D (GO:0071305) | 2.71774120 |
| 63 | glandular epithelial cell differentiation (GO:0002067) | 2.71127556 |
| 64 | macroautophagy (GO:0016236) | 2.70613855 |
| 65 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.70310870 |
| 66 | DNA double-strand break processing (GO:0000729) | 2.69989914 |
| 67 | presynaptic membrane assembly (GO:0097105) | 2.68370832 |
| 68 | L-serine transport (GO:0015825) | 2.66689142 |
| 69 | cellular response to ATP (GO:0071318) | 2.64797465 |
| 70 | double-strand break repair via nonhomologous end joining (GO:0006303) | 2.63839003 |
| 71 | non-recombinational repair (GO:0000726) | 2.63839003 |
| 72 | establishment of chromosome localization (GO:0051303) | 2.63319005 |
| 73 | negative regulation of glycogen metabolic process (GO:0070874) | 2.61679444 |
| 74 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.61346666 |
| 75 | positive regulation of glycolytic process (GO:0045821) | 2.60594429 |
| 76 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.59457747 |
| 77 | dopamine biosynthetic process (GO:0042416) | 2.59037422 |
| 78 | protein deneddylation (GO:0000338) | 2.57085832 |
| 79 | chondrocyte development (GO:0002063) | 2.57078565 |
| 80 | kinetochore organization (GO:0051383) | 2.56198447 |
| 81 | cerebellar Purkinje cell layer development (GO:0021680) | 2.56022149 |
| 82 | regulation of beta-amyloid formation (GO:1902003) | 2.55552386 |
| 83 | parental behavior (GO:0060746) | 2.55046505 |
| 84 | maternal behavior (GO:0042711) | 2.54972388 |
| 85 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.54493949 |
| 86 | regulation of peptide hormone secretion (GO:0090276) | 2.54270673 |
| 87 | response to unfolded protein (GO:0006986) | 2.53618312 |
| 88 | regulation of coenzyme metabolic process (GO:0051196) | 2.53477452 |
| 89 | regulation of cofactor metabolic process (GO:0051193) | 2.53477452 |
| 90 | regulation of centriole replication (GO:0046599) | 2.52602804 |
| 91 | mitotic sister chromatid segregation (GO:0000070) | 2.52500333 |
| 92 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.52246679 |
| 93 | regulation of peptide secretion (GO:0002791) | 2.50986902 |
| 94 | 4-hydroxyproline metabolic process (GO:0019471) | 2.48816210 |
| 95 | regulation of mitotic spindle organization (GO:0060236) | 2.47729913 |
| 96 | cellular response to glucagon stimulus (GO:0071377) | 2.47600274 |
| 97 | intestinal cholesterol absorption (GO:0030299) | 2.47471771 |
| 98 | DNA ligation (GO:0006266) | 2.47391328 |
| 99 | response to topologically incorrect protein (GO:0035966) | 2.46609159 |
| 100 | limb bud formation (GO:0060174) | 2.46321837 |
| 101 | spindle checkpoint (GO:0031577) | 2.45603827 |
| 102 | regulation of DNA endoreduplication (GO:0032875) | 2.44307474 |
| 103 | glycosphingolipid biosynthetic process (GO:0006688) | 2.43773964 |
| 104 | tRNA aminoacylation for protein translation (GO:0006418) | 2.43747323 |
| 105 | negative regulation of neurotransmitter transport (GO:0051589) | 2.43170554 |
| 106 | paraxial mesoderm development (GO:0048339) | 2.42508934 |
| 107 | positive regulation of peptide hormone secretion (GO:0090277) | 2.41782045 |
| 108 | endoplasmic reticulum organization (GO:0007029) | 2.41218470 |
| 109 | mitotic spindle organization (GO:0007052) | 2.40619257 |
| 110 | spermatid nucleus differentiation (GO:0007289) | 2.39993194 |
| 111 | positive regulation of peptide secretion (GO:0002793) | 2.39561540 |
| 112 | histone H2A acetylation (GO:0043968) | 2.39294301 |
| 113 | amino acid activation (GO:0043038) | 2.39248447 |
| 114 | tRNA aminoacylation (GO:0043039) | 2.39248447 |
| 115 | intraciliary transport (GO:0042073) | 2.38900958 |
| 116 | prostate gland growth (GO:0060736) | 2.38259669 |
| 117 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.38125495 |
| 118 | peptide secretion (GO:0002790) | 2.37320581 |
| 119 | mitotic spindle checkpoint (GO:0071174) | 2.37214727 |
| 120 | protein localization to kinetochore (GO:0034501) | 2.36756499 |
| 121 | kinetochore assembly (GO:0051382) | 2.36287868 |
| 122 | catechol-containing compound biosynthetic process (GO:0009713) | 2.35999318 |
| 123 | catecholamine biosynthetic process (GO:0042423) | 2.35999318 |
| 124 | induction of positive chemotaxis (GO:0050930) | 2.35413054 |
| 125 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.34926562 |
| 126 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.34766444 |
| 127 | lactate metabolic process (GO:0006089) | 2.34518167 |
| 128 | establishment of mitochondrion localization (GO:0051654) | 2.33830531 |
| 129 | neuron recognition (GO:0008038) | 2.33811269 |
| 130 | neural tube formation (GO:0001841) | 2.33046281 |
| 131 | Golgi organization (GO:0007030) | 2.32741299 |
| 132 | magnesium ion transport (GO:0015693) | 2.32641983 |
| 133 | establishment of viral latency (GO:0019043) | 2.32573885 |
| 134 | nonmotile primary cilium assembly (GO:0035058) | 2.32442392 |
| 135 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.32309327 |
| 136 | ribonucleoprotein complex disassembly (GO:0032988) | 2.32197901 |
| 137 | righting reflex (GO:0060013) | 2.32154620 |
| 138 | synapse assembly (GO:0007416) | 2.32137723 |
| 139 | peptide hormone secretion (GO:0030072) | 2.32094489 |
| 140 | resolution of meiotic recombination intermediates (GO:0000712) | 2.29900759 |
| 141 | regulation of sister chromatid cohesion (GO:0007063) | 2.29287098 |
| 142 | olfactory bulb development (GO:0021772) | 2.29048410 |
| 143 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.28420134 |
| 144 | nucleotide transmembrane transport (GO:1901679) | 2.28035974 |
| 145 | protein localization to synapse (GO:0035418) | 2.28022088 |
| 146 | regulation of chromosome segregation (GO:0051983) | 2.28011370 |
| 147 | regulation of hormone secretion (GO:0046883) | 2.27439871 |
| 148 | cytoskeleton-dependent intracellular transport (GO:0030705) | 2.26760274 |
| 149 | Golgi vesicle transport (GO:0048193) | 2.26745051 |
| 150 | neuron cell-cell adhesion (GO:0007158) | 2.26372881 |
| 151 | ventricular cardiac muscle cell development (GO:0055015) | 2.25644806 |
| 152 | microtubule depolymerization (GO:0007019) | 2.23724062 |
| 153 | nitric oxide mediated signal transduction (GO:0007263) | 2.23703795 |
| 154 | gastrulation with mouth forming second (GO:0001702) | 2.23151223 |
| 155 | response to follicle-stimulating hormone (GO:0032354) | 2.22740181 |
| 156 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.22727893 |
| 157 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.22413086 |
| 158 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.22285556 |
| 159 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.20959885 |
| 160 | L-phenylalanine metabolic process (GO:0006558) | 2.20959885 |
| 161 | dendritic spine morphogenesis (GO:0060997) | 2.20735785 |
| 162 | negative regulation of JUN kinase activity (GO:0043508) | 2.20564504 |
| 163 | serotonin metabolic process (GO:0042428) | 2.19901839 |
| 164 | negative regulation of meiosis (GO:0045835) | 2.19476564 |
| 165 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.18978241 |
| 166 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.18602404 |
| 167 | cell adhesion mediated by integrin (GO:0033627) | 2.18545373 |
| 168 | presynaptic membrane organization (GO:0097090) | 2.18519992 |
| 169 | ribosome assembly (GO:0042255) | 2.18103737 |
| 170 | embryonic foregut morphogenesis (GO:0048617) | 2.17971172 |
| 171 | pancreas development (GO:0031016) | 2.17694539 |
| 172 | microtubule-based transport (GO:0010970) | 2.16825062 |
| 173 | protein localization to chromosome, centromeric region (GO:0071459) | 2.16458503 |
| 174 | asymmetric protein localization (GO:0008105) | 2.14942194 |
| 175 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.14411064 |
| 176 | CENP-A containing nucleosome assembly (GO:0034080) | 2.13220234 |
| 177 | positive regulation of synapse assembly (GO:0051965) | 2.12063894 |
| 178 | cholesterol biosynthetic process (GO:0006695) | 2.11682887 |
| 179 | mitotic spindle assembly checkpoint (GO:0007094) | 2.11240047 |
| 180 | DNA damage response, detection of DNA damage (GO:0042769) | 2.11198661 |
| 181 | membrane disassembly (GO:0030397) | 2.08672265 |
| 182 | nuclear envelope disassembly (GO:0051081) | 2.08672265 |
| 183 | negative regulation of oligodendrocyte differentiation (GO:0048715) | 2.08400130 |
| 184 | peptidyl-cysteine modification (GO:0018198) | 2.08279663 |
| 185 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.08114446 |
| 186 | positive regulation of male gonad development (GO:2000020) | 2.07713768 |
| 187 | serine transport (GO:0032329) | 2.07711363 |
| 188 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.07289046 |
| 189 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.07289046 |
| 190 | negative regulation of sister chromatid segregation (GO:0033046) | 2.07289046 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.99996215 |
| 2 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.21074273 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.13357245 |
| 4 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.77864464 |
| 5 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.69553331 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.60167364 |
| 7 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.43474099 |
| 8 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.39843207 |
| 9 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.35054342 |
| 10 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.32149212 |
| 11 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.30610087 |
| 12 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.27632954 |
| 13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.22688276 |
| 14 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.21662090 |
| 15 | EWS_26573619_Chip-Seq_HEK293_Human | 2.18765088 |
| 16 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 2.08760530 |
| 17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.07470260 |
| 18 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.06946095 |
| 19 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.06346517 |
| 20 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 2.04800707 |
| 21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.01240277 |
| 22 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.00094067 |
| 23 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.99285701 |
| 24 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.98818684 |
| 25 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.97497257 |
| 26 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.95040265 |
| 27 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.89331399 |
| 28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.86445486 |
| 29 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.85878763 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.80957728 |
| 31 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.79122177 |
| 32 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.75879636 |
| 33 | GATA1_22025678_ChIP-Seq_K562_Human | 1.75751262 |
| 34 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.75128728 |
| 35 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.74760578 |
| 36 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.74093367 |
| 37 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.71879478 |
| 38 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.71259531 |
| 39 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.71044474 |
| 40 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.70742443 |
| 41 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.69614716 |
| 42 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.68260535 |
| 43 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.68107013 |
| 44 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.68107013 |
| 45 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.67868825 |
| 46 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.66465941 |
| 47 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.66344613 |
| 48 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.64181171 |
| 49 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.62260095 |
| 50 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.62055178 |
| 51 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.61039333 |
| 52 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.59471553 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.59060704 |
| 54 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.58533717 |
| 55 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.58384080 |
| 56 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.56672299 |
| 57 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.56596123 |
| 58 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.53773790 |
| 59 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.50761896 |
| 60 | FUS_26573619_Chip-Seq_HEK293_Human | 1.50286763 |
| 61 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.50061751 |
| 62 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.47481127 |
| 63 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.46334738 |
| 64 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45850947 |
| 65 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.44238853 |
| 66 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.40858435 |
| 67 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.39647273 |
| 68 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.39647273 |
| 69 | VDR_22108803_ChIP-Seq_LS180_Human | 1.39250963 |
| 70 | STAT3_23295773_ChIP-Seq_U87_Human | 1.39026093 |
| 71 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.38443502 |
| 72 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35462166 |
| 73 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.35088754 |
| 74 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34956234 |
| 75 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.34666823 |
| 76 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.33753653 |
| 77 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.33747975 |
| 78 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.33150042 |
| 79 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.32951580 |
| 80 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.32593748 |
| 81 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.32137448 |
| 82 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.31995765 |
| 83 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.30683814 |
| 84 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.26595649 |
| 85 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.25972971 |
| 86 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.25664274 |
| 87 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.25659967 |
| 88 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.24247191 |
| 89 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.22676058 |
| 90 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.21646346 |
| 91 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.21264856 |
| 92 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.21200336 |
| 93 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.20989508 |
| 94 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.20515335 |
| 95 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.19390753 |
| 96 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.18486994 |
| 97 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.18442118 |
| 98 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18136607 |
| 99 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.18014207 |
| 100 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.17922124 |
| 101 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.17704297 |
| 102 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17486427 |
| 103 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16536209 |
| 104 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14574898 |
| 105 | TCF4_23295773_ChIP-Seq_U87_Human | 1.14495191 |
| 106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.14196054 |
| 107 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.14172366 |
| 108 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.13596751 |
| 109 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.13573023 |
| 110 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.13489946 |
| 111 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.12386881 |
| 112 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.11950578 |
| 113 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.11474385 |
| 114 | REST_19997604_ChIP-ChIP_NEURONS_Mouse | 1.10900813 |
| 115 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09120328 |
| 116 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.09028058 |
| 117 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.08392182 |
| 118 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.08212152 |
| 119 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.08176214 |
| 120 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07767014 |
| 121 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.07680087 |
| 122 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.07480476 |
| 123 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.07284607 |
| 124 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07197689 |
| 125 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.04723387 |
| 126 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04385206 |
| 127 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03649800 |
| 128 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.03524609 |
| 129 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03374031 |
| 130 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.03290834 |
| 131 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02704953 |
| 132 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.02486743 |
| 133 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.01470471 |
| 134 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00774879 |
| 135 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 0.99895840 |
| 136 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.99667547 |
| 137 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99184097 |
| 138 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.98212624 |
| 139 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.97973910 |
| 140 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.97936063 |
| 141 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97931550 |
| 142 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.97406381 |
| 143 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.96906301 |
| 144 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.96906301 |
| 145 | JUN_21703547_ChIP-Seq_K562_Human | 0.96831393 |
| 146 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.96526399 |
| 147 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.96432199 |
| 148 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.96276413 |
| 149 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.96268594 |
| 150 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.95754466 |
| 151 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.95443119 |
| 152 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95220412 |
| 153 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.94181773 |
| 154 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.93658229 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003195_calcinosis | 3.75843008 |
| 2 | MP0009780_abnormal_chondrocyte_physiolo | 3.65951695 |
| 3 | MP0000013_abnormal_adipose_tissue | 3.07415711 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.04444182 |
| 5 | MP0002877_abnormal_melanocyte_morpholog | 2.84206460 |
| 6 | MP0008438_abnormal_cutaneous_collagen | 2.74926804 |
| 7 | MP0010386_abnormal_urinary_bladder | 2.70814833 |
| 8 | MP0002909_abnormal_adrenal_gland | 2.62692826 |
| 9 | MP0002693_abnormal_pancreas_physiology | 2.51701491 |
| 10 | MP0005379_endocrine/exocrine_gland_phen | 2.51113809 |
| 11 | MP0003122_maternal_imprinting | 2.49061007 |
| 12 | MP0001529_abnormal_vocalization | 2.48957684 |
| 13 | MP0005645_abnormal_hypothalamus_physiol | 2.43423118 |
| 14 | MP0001944_abnormal_pancreas_morphology | 2.41604117 |
| 15 | MP0003283_abnormal_digestive_organ | 2.33302406 |
| 16 | MP0005646_abnormal_pituitary_gland | 2.25010955 |
| 17 | MP0004043_abnormal_pH_regulation | 2.21197626 |
| 18 | MP0003890_abnormal_embryonic-extraembry | 2.11332870 |
| 19 | MP0005220_abnormal_exocrine_pancreas | 2.11091898 |
| 20 | MP0002102_abnormal_ear_morphology | 2.08584719 |
| 21 | MP0005503_abnormal_tendon_morphology | 2.07115340 |
| 22 | MP0002139_abnormal_hepatobiliary_system | 2.07048146 |
| 23 | MP0003121_genomic_imprinting | 2.01500220 |
| 24 | MP0003868_abnormal_feces_composition | 1.99201701 |
| 25 | MP0005365_abnormal_bile_salt | 1.96361097 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.92198496 |
| 27 | MP0001984_abnormal_olfaction | 1.87449675 |
| 28 | MP0002896_abnormal_bone_mineralization | 1.75146157 |
| 29 | MP0005623_abnormal_meninges_morphology | 1.75000584 |
| 30 | MP0003221_abnormal_cardiomyocyte_apopto | 1.73853675 |
| 31 | MP0006054_spinal_hemorrhage | 1.62286592 |
| 32 | MP0004270_analgesia | 1.62159287 |
| 33 | MP0002078_abnormal_glucose_homeostasis | 1.61247919 |
| 34 | MP0009697_abnormal_copulation | 1.58867710 |
| 35 | MP0000003_abnormal_adipose_tissue | 1.58326106 |
| 36 | MP0003880_abnormal_central_pattern | 1.55087776 |
| 37 | MP0003937_abnormal_limbs/digits/tail_de | 1.53681983 |
| 38 | MP0002751_abnormal_autonomic_nervous | 1.51988316 |
| 39 | MP0008877_abnormal_DNA_methylation | 1.49871207 |
| 40 | MP0003252_abnormal_bile_duct | 1.48064156 |
| 41 | MP0008058_abnormal_DNA_repair | 1.45742224 |
| 42 | MP0003959_abnormal_lean_body | 1.45699506 |
| 43 | MP0000372_irregular_coat_pigmentation | 1.45323427 |
| 44 | MP0001666_abnormal_nutrient_absorption | 1.43437491 |
| 45 | MP0005535_abnormal_body_temperature | 1.42318829 |
| 46 | MP0009046_muscle_twitch | 1.42130574 |
| 47 | MP0006276_abnormal_autonomic_nervous | 1.40606515 |
| 48 | MP0004272_abnormal_basement_membrane | 1.38404270 |
| 49 | MP0010352_gastrointestinal_tract_polyps | 1.37755681 |
| 50 | MP0000631_abnormal_neuroendocrine_gland | 1.36435162 |
| 51 | MP0001299_abnormal_eye_distance/ | 1.36125100 |
| 52 | MP0003635_abnormal_synaptic_transmissio | 1.35986252 |
| 53 | MP0002876_abnormal_thyroid_physiology | 1.35491984 |
| 54 | MP0000537_abnormal_urethra_morphology | 1.35015791 |
| 55 | MP0002938_white_spotting | 1.31382488 |
| 56 | MP0005085_abnormal_gallbladder_physiolo | 1.31183368 |
| 57 | MP0004811_abnormal_neuron_physiology | 1.30328670 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.29451096 |
| 59 | MP0008932_abnormal_embryonic_tissue | 1.29227510 |
| 60 | MP0002233_abnormal_nose_morphology | 1.28408337 |
| 61 | MP0003567_abnormal_fetal_cardiomyocyte | 1.27664409 |
| 62 | MP0009384_cardiac_valve_regurgitation | 1.27400620 |
| 63 | MP0003755_abnormal_palate_morphology | 1.25841223 |
| 64 | MP0006072_abnormal_retinal_apoptosis | 1.23864906 |
| 65 | MP0005253_abnormal_eye_physiology | 1.23757517 |
| 66 | MP0002697_abnormal_eye_size | 1.23213663 |
| 67 | MP0003787_abnormal_imprinting | 1.22671014 |
| 68 | MP0003111_abnormal_nucleus_morphology | 1.22506534 |
| 69 | MP0001188_hyperpigmentation | 1.22042292 |
| 70 | MP0005275_abnormal_skin_tensile | 1.21613132 |
| 71 | MP0000647_abnormal_sebaceous_gland | 1.20203266 |
| 72 | MP0001293_anophthalmia | 1.19980259 |
| 73 | MP0000678_abnormal_parathyroid_gland | 1.19324938 |
| 74 | MP0005408_hypopigmentation | 1.18672675 |
| 75 | MP0008057_abnormal_DNA_replication | 1.18581245 |
| 76 | MP0002063_abnormal_learning/memory/cond | 1.18395116 |
| 77 | MP0010094_abnormal_chromosome_stability | 1.18001696 |
| 78 | MP0005248_abnormal_Harderian_gland | 1.17341868 |
| 79 | MP0002295_abnormal_pulmonary_circulatio | 1.13850555 |
| 80 | MP0003077_abnormal_cell_cycle | 1.12147792 |
| 81 | MP0002734_abnormal_mechanical_nocicepti | 1.10063301 |
| 82 | MP0002084_abnormal_developmental_patter | 1.09939660 |
| 83 | MP0004957_abnormal_blastocyst_morpholog | 1.09432538 |
| 84 | MP0003385_abnormal_body_wall | 1.08565621 |
| 85 | MP0002572_abnormal_emotion/affect_behav | 1.08364950 |
| 86 | MP0004197_abnormal_fetal_growth/weight/ | 1.08260696 |
| 87 | MP0001501_abnormal_sleep_pattern | 1.06947879 |
| 88 | MP0003693_abnormal_embryo_hatching | 1.06791632 |
| 89 | MP0009745_abnormal_behavioral_response | 1.06601041 |
| 90 | MP0005058_abnormal_lysosome_morphology | 1.06309619 |
| 91 | MP0003861_abnormal_nervous_system | 1.05590461 |
| 92 | MP0005367_renal/urinary_system_phenotyp | 1.05147155 |
| 93 | MP0000516_abnormal_urinary_system | 1.05147155 |
| 94 | MP0005391_vision/eye_phenotype | 1.04598617 |
| 95 | MP0002928_abnormal_bile_duct | 1.03264453 |
| 96 | MP0000538_abnormal_urinary_bladder | 1.02699177 |
| 97 | MP0005360_urolithiasis | 1.02681202 |
| 98 | MP0000569_abnormal_digit_pigmentation | 1.01904343 |
| 99 | MP0008007_abnormal_cellular_replicative | 1.01866925 |
| 100 | MP0001765_abnormal_ion_homeostasis | 1.01297608 |
| 101 | MP0002108_abnormal_muscle_morphology | 1.01290161 |
| 102 | MP0005257_abnormal_intraocular_pressure | 1.00177673 |
| 103 | MP0005394_taste/olfaction_phenotype | 0.99968896 |
| 104 | MP0005499_abnormal_olfactory_system | 0.99968896 |
| 105 | MP0005187_abnormal_penis_morphology | 0.99488480 |
| 106 | MP0001286_abnormal_eye_development | 0.98916903 |
| 107 | MP0002009_preneoplasia | 0.98588529 |
| 108 | MP0005083_abnormal_biliary_tract | 0.97956181 |
| 109 | MP0003935_abnormal_craniofacial_develop | 0.97880340 |
| 110 | MP0003953_abnormal_hormone_level | 0.97831767 |
| 111 | MP0005423_abnormal_somatic_nervous | 0.97156182 |
| 112 | MP0000462_abnormal_digestive_system | 0.96082078 |
| 113 | MP0001177_atelectasis | 0.94802551 |
| 114 | MP0002092_abnormal_eye_morphology | 0.94611287 |
| 115 | MP0000681_abnormal_thyroid_gland | 0.94389285 |
| 116 | MP0000778_abnormal_nervous_system | 0.94263076 |
| 117 | MP0003136_yellow_coat_color | 0.94168549 |
| 118 | MP0008995_early_reproductive_senescence | 0.93942927 |
| 119 | MP0009703_decreased_birth_body | 0.92090997 |
| 120 | MP0000639_abnormal_adrenal_gland | 0.91694564 |
| 121 | MP0005084_abnormal_gallbladder_morpholo | 0.91573935 |
| 122 | MP0002882_abnormal_neuron_morphology | 0.91072980 |
| 123 | MP0002733_abnormal_thermal_nociception | 0.89075355 |
| 124 | MP0001502_abnormal_circadian_rhythm | 0.88159072 |
| 125 | MP0002152_abnormal_brain_morphology | 0.87961098 |
| 126 | MP0000230_abnormal_systemic_arterial | 0.87833634 |
| 127 | MP0002064_seizures | 0.86954017 |
| 128 | MP0004859_abnormal_synaptic_plasticity | 0.86934234 |
| 129 | MP0002081_perinatal_lethality | 0.86658454 |
| 130 | MP0003115_abnormal_respiratory_system | 0.86017090 |
| 131 | MP0002557_abnormal_social/conspecific_i | 0.85989811 |
| 132 | MP0000955_abnormal_spinal_cord | 0.84826594 |
| 133 | MP0002177_abnormal_outer_ear | 0.84335120 |
| 134 | MP0002736_abnormal_nociception_after | 0.83820819 |
| 135 | MP0003786_premature_aging | 0.83526064 |
| 136 | MP0003941_abnormal_skin_development | 0.83379964 |
| 137 | MP0002085_abnormal_embryonic_tissue | 0.83297989 |
| 138 | MP0003942_abnormal_urinary_system | 0.83249297 |
| 139 | MP0000613_abnormal_salivary_gland | 0.81725343 |
| 140 | MP0004264_abnormal_extraembryonic_tissu | 0.81674589 |
| 141 | MP0003119_abnormal_digestive_system | 0.81070067 |
| 142 | MP0002090_abnormal_vision | 0.80724458 |
| 143 | MP0000163_abnormal_cartilage_morphology | 0.80463410 |
| 144 | MP0008789_abnormal_olfactory_epithelium | 0.80062347 |
| 145 | MP0005448_abnormal_energy_balance | 0.80031647 |
| 146 | MP0002282_abnormal_trachea_morphology | 0.79931581 |
| 147 | MP0005171_absent_coat_pigmentation | 0.79606911 |
| 148 | MP0003634_abnormal_glial_cell | 0.79589064 |
| 149 | MP0002184_abnormal_innervation | 0.78981580 |
| 150 | MP0001697_abnormal_embryo_size | 0.78847619 |
| 151 | MP0003329_amyloid_beta_deposits | 0.78264784 |
| 152 | MP0002272_abnormal_nervous_system | 0.78246012 |
| 153 | MP0003172_abnormal_lysosome_physiology | 0.76807187 |
| 154 | MP0001440_abnormal_grooming_behavior | 0.76683972 |
| 155 | MP0003300_gastrointestinal_ulcer | 0.74788901 |
| 156 | MP0001664_abnormal_digestion | 0.74456711 |
| 157 | MP0008875_abnormal_xenobiotic_pharmacok | 0.74346639 |
| 158 | MP0004924_abnormal_behavior | 0.73570924 |
| 159 | MP0005386_behavior/neurological_phenoty | 0.73570924 |
| 160 | MP0000920_abnormal_myelination | 0.73446987 |
| 161 | MP0002234_abnormal_pharynx_morphology | 0.72633913 |
| 162 | MP0005636_abnormal_mineral_homeostasis | 0.71692893 |
| 163 | MP0002168_other_aberrant_phenotype | 0.71473164 |
| 164 | MP0002118_abnormal_lipid_homeostasis | 0.70634120 |
| 165 | MP0002163_abnormal_gland_morphology | 0.70234700 |
| 166 | MP0003045_fibrosis | 0.69690931 |
| 167 | MP0002069_abnormal_eating/drinking_beha | 0.69242244 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 4.91350757 |
| 2 | Hypoglycemic seizures (HP:0002173) | 4.88344167 |
| 3 | Symptomatic seizures (HP:0011145) | 4.87572713 |
| 4 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 4.74905259 |
| 5 | Cortical dysplasia (HP:0002539) | 4.63467202 |
| 6 | Hypoglycemic coma (HP:0001325) | 3.99605986 |
| 7 | Conjugated hyperbilirubinemia (HP:0002908) | 3.72755151 |
| 8 | Abnormality of the intrinsic pathway (HP:0010989) | 3.71426370 |
| 9 | Agitation (HP:0000713) | 3.66579493 |
| 10 | Hyperglycemia (HP:0003074) | 3.51965770 |
| 11 | Abnormality of the pancreatic islet cells (HP:0006476) | 3.40705360 |
| 12 | Abnormality of endocrine pancreas physiology (HP:0012093) | 3.40705360 |
| 13 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.33986994 |
| 14 | Pancreatic islet-cell hyperplasia (HP:0004510) | 3.28628010 |
| 15 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.26937581 |
| 16 | Abnormality of the common coagulation pathway (HP:0010990) | 3.23849836 |
| 17 | Ketoacidosis (HP:0001993) | 3.12345938 |
| 18 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.04072234 |
| 19 | Hypothermia (HP:0002045) | 3.02389898 |
| 20 | Papillary thyroid carcinoma (HP:0002895) | 2.89870856 |
| 21 | Volvulus (HP:0002580) | 2.88034804 |
| 22 | EEG with generalized epileptiform discharges (HP:0011198) | 2.81821294 |
| 23 | Abnormal pancreas size (HP:0012094) | 2.81461559 |
| 24 | Epileptiform EEG discharges (HP:0011182) | 2.78189844 |
| 25 | Hypsarrhythmia (HP:0002521) | 2.75159517 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.74256879 |
| 27 | Mucopolysacchariduria (HP:0008155) | 2.74256879 |
| 28 | Abnormality of the corticospinal tract (HP:0002492) | 2.74027398 |
| 29 | Shoulder girdle muscle weakness (HP:0003547) | 2.71270124 |
| 30 | Abnormal lung lobation (HP:0002101) | 2.64455516 |
| 31 | Papilledema (HP:0001085) | 2.63544868 |
| 32 | Thyroid carcinoma (HP:0002890) | 2.60558947 |
| 33 | Dysostosis multiplex (HP:0000943) | 2.59188009 |
| 34 | Intestinal atresia (HP:0011100) | 2.52742136 |
| 35 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.52583671 |
| 36 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.52583671 |
| 37 | Skin nodule (HP:0200036) | 2.47560390 |
| 38 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.44654947 |
| 39 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.44654947 |
| 40 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.44654947 |
| 41 | Pheochromocytoma (HP:0002666) | 2.44043837 |
| 42 | Hepatoblastoma (HP:0002884) | 2.43199788 |
| 43 | Macroorchidism (HP:0000053) | 2.41138498 |
| 44 | Cerebral inclusion bodies (HP:0100314) | 2.40495375 |
| 45 | Intrahepatic cholestasis (HP:0001406) | 2.39175864 |
| 46 | Blue irides (HP:0000635) | 2.37801064 |
| 47 | Neurofibrillary tangles (HP:0002185) | 2.30598537 |
| 48 | Amyotrophic lateral sclerosis (HP:0007354) | 2.29423948 |
| 49 | Abnormality of the lower motor neuron (HP:0002366) | 2.27538197 |
| 50 | Prolonged partial thromboplastin time (HP:0003645) | 2.24447868 |
| 51 | Congenital glaucoma (HP:0001087) | 2.24415597 |
| 52 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.24389219 |
| 53 | Osteomalacia (HP:0002749) | 2.21537521 |
| 54 | Type II lissencephaly (HP:0007260) | 2.20818771 |
| 55 | Ependymoma (HP:0002888) | 2.18597051 |
| 56 | Neuroendocrine neoplasm (HP:0100634) | 2.18383658 |
| 57 | Astrocytoma (HP:0009592) | 2.16020928 |
| 58 | Abnormality of the astrocytes (HP:0100707) | 2.16020928 |
| 59 | Hypokalemia (HP:0002900) | 2.10900964 |
| 60 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.09756416 |
| 61 | Spastic diplegia (HP:0001264) | 2.07558019 |
| 62 | Protuberant abdomen (HP:0001538) | 2.07360916 |
| 63 | Retinal atrophy (HP:0001105) | 2.07054254 |
| 64 | Buphthalmos (HP:0000557) | 2.06766032 |
| 65 | Urinary urgency (HP:0000012) | 2.05047896 |
| 66 | Large for gestational age (HP:0001520) | 2.02453355 |
| 67 | Fat malabsorption (HP:0002630) | 2.01229136 |
| 68 | Gait imbalance (HP:0002141) | 1.99948266 |
| 69 | Generalized aminoaciduria (HP:0002909) | 1.99625887 |
| 70 | Late onset (HP:0003584) | 1.99368273 |
| 71 | Atonic seizures (HP:0010819) | 1.97655835 |
| 72 | Ketosis (HP:0001946) | 1.95397253 |
| 73 | Postural tremor (HP:0002174) | 1.95347601 |
| 74 | Limb-girdle muscle weakness (HP:0003325) | 1.93650777 |
| 75 | Hypophosphatemia (HP:0002148) | 1.93484921 |
| 76 | Insidious onset (HP:0003587) | 1.92014363 |
| 77 | Termporal pattern (HP:0011008) | 1.92014363 |
| 78 | Increased nuchal translucency (HP:0010880) | 1.91501099 |
| 79 | Upper limb muscle weakness (HP:0003484) | 1.91213569 |
| 80 | Congenital primary aphakia (HP:0007707) | 1.90188515 |
| 81 | Glioma (HP:0009733) | 1.90113416 |
| 82 | Abnormality of the metopic suture (HP:0005556) | 1.89288059 |
| 83 | Thoracolumbar scoliosis (HP:0002944) | 1.89114025 |
| 84 | Decreased circulating renin level (HP:0003351) | 1.88824099 |
| 85 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.88553637 |
| 86 | Restlessness (HP:0000711) | 1.87923447 |
| 87 | Visual hallucinations (HP:0002367) | 1.86736536 |
| 88 | Abnormality of dentin (HP:0010299) | 1.86591509 |
| 89 | Postnatal microcephaly (HP:0005484) | 1.86147530 |
| 90 | Abnormality of the anterior horn cell (HP:0006802) | 1.85212831 |
| 91 | Degeneration of anterior horn cells (HP:0002398) | 1.85212831 |
| 92 | Embryonal renal neoplasm (HP:0011794) | 1.83964789 |
| 93 | Hyperphosphaturia (HP:0003109) | 1.83640306 |
| 94 | Lissencephaly (HP:0001339) | 1.81081794 |
| 95 | Abnormality of the labia minora (HP:0012880) | 1.79539854 |
| 96 | Colon cancer (HP:0003003) | 1.79218770 |
| 97 | Infantile muscular hypotonia (HP:0008947) | 1.78794806 |
| 98 | Abdominal distention (HP:0003270) | 1.78505541 |
| 99 | Spastic gait (HP:0002064) | 1.78463493 |
| 100 | Medulloblastoma (HP:0002885) | 1.78403000 |
| 101 | Genital tract atresia (HP:0001827) | 1.77581436 |
| 102 | Medial flaring of the eyebrow (HP:0010747) | 1.77444503 |
| 103 | Complement deficiency (HP:0004431) | 1.76408370 |
| 104 | Arterial tortuosity (HP:0005116) | 1.76144608 |
| 105 | Abnormal auditory evoked potentials (HP:0006958) | 1.74700514 |
| 106 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.74496345 |
| 107 | Spastic tetraplegia (HP:0002510) | 1.74042860 |
| 108 | Absent eyebrow (HP:0002223) | 1.73494462 |
| 109 | Limb dystonia (HP:0002451) | 1.73203582 |
| 110 | Enlarged epiphyses (HP:0010580) | 1.73039135 |
| 111 | Vascular tortuosity (HP:0004948) | 1.72764344 |
| 112 | Large earlobe (HP:0009748) | 1.72084243 |
| 113 | Nephrogenic diabetes insipidus (HP:0009806) | 1.71917833 |
| 114 | Neoplasm of the thyroid gland (HP:0100031) | 1.71149383 |
| 115 | Hypophosphatemic rickets (HP:0004912) | 1.71001295 |
| 116 | Resting tremor (HP:0002322) | 1.70826820 |
| 117 | Drooling (HP:0002307) | 1.70604670 |
| 118 | Excessive salivation (HP:0003781) | 1.70604670 |
| 119 | Failure to thrive in infancy (HP:0001531) | 1.70402516 |
| 120 | Abnormality of potassium homeostasis (HP:0011042) | 1.70235706 |
| 121 | Vaginal atresia (HP:0000148) | 1.70163732 |
| 122 | Abnormal glycosylation (HP:0012345) | 1.70048527 |
| 123 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.70048527 |
| 124 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.70048527 |
| 125 | Abnormal protein glycosylation (HP:0012346) | 1.70048527 |
| 126 | Hyperparathyroidism (HP:0000843) | 1.69333726 |
| 127 | Pelvic girdle muscle weakness (HP:0003749) | 1.69285097 |
| 128 | Bifid tongue (HP:0010297) | 1.68974284 |
| 129 | Lower limb muscle weakness (HP:0007340) | 1.67484570 |
| 130 | Paraplegia (HP:0010550) | 1.65855413 |
| 131 | Postaxial hand polydactyly (HP:0001162) | 1.65345581 |
| 132 | Epiphyseal dysplasia (HP:0002656) | 1.63362230 |
| 133 | Premature rupture of membranes (HP:0001788) | 1.63300212 |
| 134 | Muscular hypotonia of the trunk (HP:0008936) | 1.63274576 |
| 135 | Anxiety (HP:0000739) | 1.63200958 |
| 136 | Hand muscle atrophy (HP:0009130) | 1.62131561 |
| 137 | Absence seizures (HP:0002121) | 1.61529722 |
| 138 | Short tibia (HP:0005736) | 1.61417215 |
| 139 | Prominent metopic ridge (HP:0005487) | 1.60629357 |
| 140 | Thin bony cortex (HP:0002753) | 1.60455138 |
| 141 | Truncal ataxia (HP:0002078) | 1.60206185 |
| 142 | Spastic paraplegia (HP:0001258) | 1.59971943 |
| 143 | Generalized hypopigmentation of hair (HP:0011358) | 1.59588294 |
| 144 | Aqueductal stenosis (HP:0002410) | 1.59558024 |
| 145 | Micropenis (HP:0000054) | 1.59498971 |
| 146 | Broad foot (HP:0001769) | 1.58176256 |
| 147 | Oligomenorrhea (HP:0000876) | 1.57327867 |
| 148 | Hyperventilation (HP:0002883) | 1.56995688 |
| 149 | Gastrointestinal atresia (HP:0002589) | 1.56557001 |
| 150 | Labial hypoplasia (HP:0000066) | 1.56496981 |
| 151 | Hypoplasia of the fovea (HP:0007750) | 1.56227638 |
| 152 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.56227638 |
| 153 | Insulin resistance (HP:0000855) | 1.56139916 |
| 154 | Exostoses (HP:0100777) | 1.55993211 |
| 155 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.55620614 |
| 156 | Hypoplasia of the brainstem (HP:0002365) | 1.55620614 |
| 157 | Retinal dysplasia (HP:0007973) | 1.55571881 |
| 158 | Delayed gross motor development (HP:0002194) | 1.55509925 |
| 159 | Meckel diverticulum (HP:0002245) | 1.55383123 |
| 160 | Rhabdomyosarcoma (HP:0002859) | 1.54785067 |
| 161 | Chronic hepatic failure (HP:0100626) | 1.54728576 |
| 162 | Narrow forehead (HP:0000341) | 1.53924998 |
| 163 | Specific learning disability (HP:0001328) | 1.53831510 |
| 164 | Disproportionate short-trunk short stature (HP:0003521) | 1.53571427 |
| 165 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.53381548 |
| 166 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.53381548 |
| 167 | Ovarian neoplasm (HP:0100615) | 1.52998365 |
| 168 | Hypoventilation (HP:0002791) | 1.52709189 |
| 169 | Patchy hypopigmentation of hair (HP:0011365) | 1.52256586 |
| 170 | Bronchomalacia (HP:0002780) | 1.51826460 |
| 171 | Rimmed vacuoles (HP:0003805) | 1.51759151 |
| 172 | Follicular hyperkeratosis (HP:0007502) | 1.51185642 |
| 173 | Enlarged kidneys (HP:0000105) | 1.51064550 |
| 174 | Overlapping toe (HP:0001845) | 1.50543308 |
| 175 | True hermaphroditism (HP:0010459) | 1.48967357 |
| 176 | Open mouth (HP:0000194) | 1.48673681 |
| 177 | Abnormality of the ileum (HP:0001549) | 1.48559960 |
| 178 | Hypoplastic pelvis (HP:0008839) | 1.47806177 |
| 179 | Vertebral arch anomaly (HP:0008438) | 1.47190486 |
| 180 | Freckling (HP:0001480) | 1.46662561 |
| 181 | Tetraparesis (HP:0002273) | 1.46243800 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | INSRR | 5.40510928 |
| 2 | FRK | 4.15669837 |
| 3 | TRIM28 | 3.59478103 |
| 4 | NTRK3 | 2.89433711 |
| 5 | TAOK3 | 2.88366968 |
| 6 | SRPK1 | 2.68360165 |
| 7 | PASK | 2.65792221 |
| 8 | TSSK6 | 2.39184343 |
| 9 | PBK | 2.33511439 |
| 10 | SCYL2 | 2.21774087 |
| 11 | MAP3K2 | 2.09577136 |
| 12 | BRD4 | 2.09367193 |
| 13 | MAPK15 | 2.09227283 |
| 14 | NEK1 | 1.99100726 |
| 15 | NTRK1 | 1.97433704 |
| 16 | BUB1 | 1.95688386 |
| 17 | CASK | 1.93453324 |
| 18 | EIF2AK1 | 1.91198012 |
| 19 | WEE1 | 1.84047500 |
| 20 | PLK3 | 1.81020715 |
| 21 | PDGFRA | 1.77489479 |
| 22 | STK38L | 1.77015483 |
| 23 | UHMK1 | 1.76861954 |
| 24 | MKNK1 | 1.74613473 |
| 25 | MAP3K4 | 1.74004838 |
| 26 | HIPK2 | 1.67629507 |
| 27 | MKNK2 | 1.64932263 |
| 28 | FGFR2 | 1.63299725 |
| 29 | EPHA3 | 1.61440245 |
| 30 | TTK | 1.56342243 |
| 31 | PNCK | 1.54555204 |
| 32 | CCNB1 | 1.53959984 |
| 33 | SIK3 | 1.51053688 |
| 34 | AKT3 | 1.50696728 |
| 35 | CAMKK2 | 1.49281542 |
| 36 | WNK4 | 1.48241431 |
| 37 | MARK1 | 1.46780176 |
| 38 | LATS1 | 1.45543100 |
| 39 | PAK3 | 1.44459079 |
| 40 | FER | 1.44245321 |
| 41 | MET | 1.42007210 |
| 42 | WNK3 | 1.39941382 |
| 43 | CSNK1G1 | 1.35534347 |
| 44 | MAP2K7 | 1.31112574 |
| 45 | BMPR1B | 1.30098371 |
| 46 | PLK4 | 1.29294118 |
| 47 | MAP4K2 | 1.27242245 |
| 48 | BCR | 1.26958426 |
| 49 | DDR2 | 1.23777620 |
| 50 | PRKCE | 1.21048767 |
| 51 | PLK2 | 1.16656370 |
| 52 | ERBB3 | 1.14387473 |
| 53 | MAP2K4 | 1.12271141 |
| 54 | RET | 1.08461109 |
| 55 | EPHA4 | 1.07290468 |
| 56 | PRKD3 | 1.07067679 |
| 57 | GRK7 | 1.05071904 |
| 58 | PIK3CG | 1.03872780 |
| 59 | RPS6KA4 | 1.02232823 |
| 60 | PAK6 | 1.01307400 |
| 61 | BRSK2 | 0.92347351 |
| 62 | CDC7 | 0.91918035 |
| 63 | CAMK2B | 0.91858053 |
| 64 | DYRK3 | 0.91548626 |
| 65 | PLK1 | 0.90737604 |
| 66 | ERBB4 | 0.90425877 |
| 67 | EIF2AK3 | 0.90168626 |
| 68 | ERN1 | 0.90080346 |
| 69 | MAP3K12 | 0.88508359 |
| 70 | CAMK1G | 0.88320379 |
| 71 | STK39 | 0.88138902 |
| 72 | MINK1 | 0.86318663 |
| 73 | YES1 | 0.85775843 |
| 74 | CAMK2A | 0.83790368 |
| 75 | STK3 | 0.83612155 |
| 76 | FGR | 0.83400302 |
| 77 | WNK1 | 0.83110141 |
| 78 | PTK2 | 0.82991718 |
| 79 | CDC42BPA | 0.81268034 |
| 80 | PIK3CA | 0.81033305 |
| 81 | CAMK2D | 0.80728184 |
| 82 | CDK18 | 0.78571847 |
| 83 | PRKCH | 0.77998098 |
| 84 | MST1R | 0.77400520 |
| 85 | KSR1 | 0.77297564 |
| 86 | MAP3K1 | 0.75376050 |
| 87 | LATS2 | 0.75373599 |
| 88 | CDK5 | 0.74641124 |
| 89 | CAMK1D | 0.74342862 |
| 90 | DYRK2 | 0.74208492 |
| 91 | PDGFRB | 0.72782898 |
| 92 | NUAK1 | 0.71495898 |
| 93 | CDK14 | 0.70661059 |
| 94 | BCKDK | 0.67029176 |
| 95 | FGFR1 | 0.66683543 |
| 96 | SIK1 | 0.66652556 |
| 97 | CSNK1G2 | 0.66170051 |
| 98 | ACVR1B | 0.66006037 |
| 99 | EIF2AK2 | 0.65566850 |
| 100 | MAPK13 | 0.65158403 |
| 101 | CDK15 | 0.64046462 |
| 102 | BRSK1 | 0.62634200 |
| 103 | SGK494 | 0.62629209 |
| 104 | SGK223 | 0.62629209 |
| 105 | GRK5 | 0.62380299 |
| 106 | BMPR2 | 0.61644792 |
| 107 | ADRBK1 | 0.61435358 |
| 108 | IGF1R | 0.60811748 |
| 109 | TNIK | 0.58777144 |
| 110 | CLK1 | 0.58711246 |
| 111 | NTRK2 | 0.58257162 |
| 112 | OXSR1 | 0.57523987 |
| 113 | GSK3A | 0.57003184 |
| 114 | EPHB2 | 0.56927903 |
| 115 | CDK11A | 0.56057938 |
| 116 | PRKCG | 0.55313848 |
| 117 | IRAK2 | 0.54024737 |
| 118 | ATM | 0.52770501 |
| 119 | IRAK1 | 0.51363593 |
| 120 | PRKG1 | 0.50441700 |
| 121 | ZAK | 0.49047063 |
| 122 | NEK6 | 0.48555693 |
| 123 | SGK2 | 0.48546809 |
| 124 | ADRBK2 | 0.48166228 |
| 125 | BRAF | 0.47682724 |
| 126 | RPS6KA2 | 0.47133289 |
| 127 | PTK6 | 0.47080178 |
| 128 | PINK1 | 0.46951278 |
| 129 | SGK1 | 0.45952448 |
| 130 | IRAK3 | 0.45920225 |
| 131 | FLT3 | 0.44569442 |
| 132 | MAP3K6 | 0.44197466 |
| 133 | CSNK1G3 | 0.43165013 |
| 134 | JAK1 | 0.42348475 |
| 135 | DYRK1A | 0.41591613 |
| 136 | NEK2 | 0.41370211 |
| 137 | LIMK1 | 0.40947913 |
| 138 | RPS6KB1 | 0.40735531 |
| 139 | STK16 | 0.40379351 |
| 140 | MYLK | 0.39975645 |
| 141 | PRKACA | 0.39432525 |
| 142 | PRKACG | 0.39035900 |
| 143 | JAK2 | 0.38594280 |
| 144 | NEK9 | 0.38285983 |
| 145 | DYRK1B | 0.38256238 |
| 146 | CSNK1A1L | 0.37783003 |
| 147 | INSR | 0.37766694 |
| 148 | AURKB | 0.37547929 |
| 149 | CHEK2 | 0.37438928 |
| 150 | CDK6 | 0.37206188 |
| 151 | CAMK2G | 0.36842947 |
| 152 | FES | 0.35188355 |
| 153 | CHEK1 | 0.34839470 |
| 154 | VRK1 | 0.32925307 |
| 155 | CDK1 | 0.30338791 |
| 156 | ATR | 0.29178759 |
| 157 | CSNK1E | 0.27973766 |
| 158 | PRKDC | 0.27679195 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 5.74043976 |
| 2 | Protein export_Homo sapiens_hsa03060 | 5.00787190 |
| 3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.11611780 |
| 4 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.92323604 |
| 5 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 2.76953073 |
| 6 | Insulin secretion_Homo sapiens_hsa04911 | 2.27549552 |
| 7 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.27391392 |
| 8 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.19083597 |
| 9 | Cocaine addiction_Homo sapiens_hsa05030 | 1.85054147 |
| 10 | RNA transport_Homo sapiens_hsa03013 | 1.79419960 |
| 11 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.67418504 |
| 12 | Cell cycle_Homo sapiens_hsa04110 | 1.63109747 |
| 13 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.52149145 |
| 14 | Basal transcription factors_Homo sapiens_hsa03022 | 1.48684315 |
| 15 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.47902011 |
| 16 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.46139260 |
| 17 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.45347691 |
| 18 | Oocyte meiosis_Homo sapiens_hsa04114 | 1.45335778 |
| 19 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.44541534 |
| 20 | GABAergic synapse_Homo sapiens_hsa04727 | 1.43509038 |
| 21 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.43091807 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.41618137 |
| 23 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.41393671 |
| 24 | Mismatch repair_Homo sapiens_hsa03430 | 1.37032502 |
| 25 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.34788566 |
| 26 | Spliceosome_Homo sapiens_hsa03040 | 1.34506210 |
| 27 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.32653174 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.29484872 |
| 29 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.26606042 |
| 30 | Proteasome_Homo sapiens_hsa03050 | 1.25094615 |
| 31 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.24367957 |
| 32 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.24329797 |
| 33 | RNA degradation_Homo sapiens_hsa03018 | 1.22480199 |
| 34 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.21504730 |
| 35 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.20079235 |
| 36 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.18643932 |
| 37 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.18503322 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.17850467 |
| 39 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.17785194 |
| 40 | Nicotine addiction_Homo sapiens_hsa05033 | 1.17385889 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.16992908 |
| 42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.15285559 |
| 43 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.12471374 |
| 44 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.07189620 |
| 45 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.04418275 |
| 46 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.03468963 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.03309760 |
| 48 | Prion diseases_Homo sapiens_hsa05020 | 1.03180110 |
| 49 | Morphine addiction_Homo sapiens_hsa05032 | 1.03039659 |
| 50 | Circadian entrainment_Homo sapiens_hsa04713 | 1.01435873 |
| 51 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.01431581 |
| 52 | Renin secretion_Homo sapiens_hsa04924 | 1.01119753 |
| 53 | Long-term potentiation_Homo sapiens_hsa04720 | 1.00858095 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00745321 |
| 55 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.99069331 |
| 56 | Lysosome_Homo sapiens_hsa04142 | 0.97437764 |
| 57 | Taste transduction_Homo sapiens_hsa04742 | 0.96633519 |
| 58 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.94727929 |
| 59 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.93757944 |
| 60 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.92815364 |
| 61 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.91188760 |
| 62 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.90873828 |
| 63 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.90709691 |
| 64 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.89771917 |
| 65 | Adherens junction_Homo sapiens_hsa04520 | 0.88327994 |
| 66 | Phagosome_Homo sapiens_hsa04145 | 0.88300728 |
| 67 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.88153473 |
| 68 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.87778531 |
| 69 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.87268489 |
| 70 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.85297439 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.82822051 |
| 72 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82569510 |
| 73 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.82277864 |
| 74 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.80289354 |
| 75 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.79744178 |
| 76 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.79286140 |
| 77 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.78326063 |
| 78 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77016061 |
| 79 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.75931302 |
| 80 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.74576784 |
| 81 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.74509673 |
| 82 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.74439101 |
| 83 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.73817617 |
| 84 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.73279838 |
| 85 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.72712398 |
| 86 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.72495730 |
| 87 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.71982637 |
| 88 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.68541581 |
| 89 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.67924276 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.67153103 |
| 91 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67058121 |
| 92 | Long-term depression_Homo sapiens_hsa04730 | 0.66512275 |
| 93 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.65137127 |
| 94 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.65101064 |
| 95 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.62970849 |
| 96 | Colorectal cancer_Homo sapiens_hsa05210 | 0.61609446 |
| 97 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57110817 |
| 98 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56908179 |
| 99 | Tight junction_Homo sapiens_hsa04530 | 0.54786383 |
| 100 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.54175608 |
| 101 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.53776908 |
| 102 | RNA polymerase_Homo sapiens_hsa03020 | 0.52956702 |
| 103 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.52847418 |
| 104 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.52286266 |
| 105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51989519 |
| 106 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51950856 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.51643784 |
| 108 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.50994337 |
| 109 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.48571998 |
| 110 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.48562052 |
| 111 | Melanoma_Homo sapiens_hsa05218 | 0.48327213 |
| 112 | Axon guidance_Homo sapiens_hsa04360 | 0.47942335 |
| 113 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.47641267 |
| 114 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.46420338 |
| 115 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.46293425 |
| 116 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.46037666 |
| 117 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45978324 |
| 118 | ABC transporters_Homo sapiens_hsa02010 | 0.45725680 |
| 119 | Insulin resistance_Homo sapiens_hsa04931 | 0.45115965 |
| 120 | DNA replication_Homo sapiens_hsa03030 | 0.44751864 |
| 121 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.44501676 |
| 122 | Circadian rhythm_Homo sapiens_hsa04710 | 0.43741854 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.43638220 |
| 124 | Carbon metabolism_Homo sapiens_hsa01200 | 0.42983748 |
| 125 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.42958802 |
| 126 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.42915157 |
| 127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.42847835 |
| 128 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.42777455 |
| 129 | Gap junction_Homo sapiens_hsa04540 | 0.42294770 |
| 130 | Glioma_Homo sapiens_hsa05214 | 0.42227417 |
| 131 | Prostate cancer_Homo sapiens_hsa05215 | 0.42133408 |
| 132 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42031665 |
| 133 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.40947370 |
| 134 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.39750866 |
| 135 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.39430181 |
| 136 | Salivary secretion_Homo sapiens_hsa04970 | 0.39184820 |
| 137 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.39144422 |
| 138 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39094961 |
| 139 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.38937256 |
| 140 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37500373 |
| 141 | Alcoholism_Homo sapiens_hsa05034 | 0.37029579 |
| 142 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.36750943 |
| 143 | Melanogenesis_Homo sapiens_hsa04916 | 0.35373056 |
| 144 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.35175223 |
| 145 | Focal adhesion_Homo sapiens_hsa04510 | 0.34596094 |
| 146 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34429028 |
| 147 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.34305885 |
| 148 | Peroxisome_Homo sapiens_hsa04146 | 0.34204600 |
| 149 | Bile secretion_Homo sapiens_hsa04976 | 0.33866478 |
| 150 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.32423258 |
| 151 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.31437147 |
| 152 | Purine metabolism_Homo sapiens_hsa00230 | 0.31180112 |

